InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2024-12-20 00:00:00 ET · period of report 2024-12-19 · accession 0001562180-24-008538 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-12-20 2024-12-19 UTHR MAHON PAUL A EVP, GC M - OptEx $163.30 +7,700 44.4K +21% +$1.26M
DT 2024-12-20 2024-12-19 UTHR MAHON PAUL A EVP, GC D - Sale to Iss $360.16 -7,700 36.7K -17% -$2.77M
DT 2024-12-20 2024-12-19 UTHR MAHON PAUL A EVP, GC M - OptEx $0.00 -7,700 37.4K -17% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-12-19 M A 7,700 $163.30 44,410 D — —
2 Common Common Stock 2024-12-19 D D 7,700 $360.16 36,710 D — —
3 Derivative Share Tracking Award 2024-12-19 M D 7,700 $0.00 37,350 D $163.30 · 2016-03-13 to 2025-03-13 7,700 Common Stock (F2) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.